2019 NHCA Annual Conference has ended
Back To Schedule
Friday, February 8 • 9:25am - 9:45am
Otoprotective Pharmacologic Agents: The Way Forward

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
For over 2 decades we have been hearing about pharmacologic otoprotective agents moving towards clinical use for noise- and drug-induced hearing loss. So why do we not yet have any FDA approved agents available? At what stage of development are we now? This lecture will discuss some of the issues in the approval process including clinical trials populations, clinical trials for temporary threshold shift versus permanent threshold shift, prophylaxis versus rescue, the use of FDA approved versus new agents in clinical trials, intellectual property issues, approval processes, drug delivery methods, safety and efficacy determinations and how advancements in one area can facilitate developments in other areas.  The purpose of this presentation is to update clinical audiologists on the bench to bedside process of otoprotective agent development and to help them understand how they may be able to assist in the process and how they can respond to inquiries from patients and physicians.  Once at least one of these agents is approved, this session should also help clinical audiologists understand how the area could further develop and expand for additional populations and applications.  Time will be allotted for questions.


Kathleen Campbell, CCC-A, PhD, Research Professor and Distinguished Scholar

Southern Illinois University School of Medicine
Kathleen CM Campbell, PhD is Research Professor and Distinguished Scholar at SIU School of Medicine in Springfield IL. She was a clinical audiologist for over 25 years but now focuses on NIH/DoD funded research only in ototoxicity/otoprotective agents. She has received Honors of the... Read More →

Friday February 8, 2019 9:25am - 9:45am PST
Grapevine A